Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
- Status
- COMPLETED
- Phase
- PHASE3
Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
- Status
- COMPLETED
- Phase
- N/A
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
- Status
- COMPLETED
- Phase
- PHASE2
Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MK0457 in Patients With Leukemia (0457-003)
- Status
- COMPLETED
- Phase
- PHASE1